Dana Goldman and Darius Lakdawalla are evaluating affordable ways to address the rising number of Alzheimer’s disease and related dementias patients, including developing novel reimbursement frameworks, to ensure these patients have access when an innovative treatment becomes available.
Other featured articles
Diabetes Studies Reveal How Insurance and Ethnicity Can Affect Outcomes
USC Schaeffer Center experts found significant racial and ethnic disparities in diabetes complications and examined the impact of the ACA on patients with diabetes in two separate studies.
Becerra Emphasizes Bold Solutions at USC-Brookings Schaeffer Initiative Event on Paths to Universal Coverage
In a panel discussion, Schaeffer experts outline policy approaches to improve the current healthcare system, following keynote remarks by California Attorney General Xavier Becerra.
Rosalie Liccardo Pacula Named Inaugural Elizabeth Garrett Chair in Health Policy, Economics, and Law
Rosalie Liccardo Pacula is a nationally recognized expert in the economics of substance use and addiction, including opioids, cannabis, and alcohol.
Using the Drug Pricing Netflix Model to Help States Tackle the Hep C Crisis
Researcher Neeraj Sood has explored innovative payment models as a strategy for government entities to be able to pay for lifesaving cures that could eradicate diseases like hepatitis C. Louisiana, with some input from Sood, has just implemented a modified version of a subscription model to pay for Hep C treatments.